InflaRx N.V. — Investor Relations & Filings
InflaRx N.V. is a clinical-stage biopharmaceutical company that develops anti-inflammatory therapeutics. The company focuses on applying its proprietary technology to discover and develop inhibitors of the complement activation factor C5a and its receptor, C5aR. This approach targets the C5a/C5aR signaling pathway to treat life-threatening and debilitating inflammatory diseases with high unmet medical needs. Its lead product, vilobelimab (GOHIBIC), has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for the treatment of critically ill, hospitalized adult COVID-19 patients under specific conditions. InflaRx's pipeline aims to develop first-in-class agents for various inflammatory conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B5 - InflaRx N.V. (0001708688) (Filer) | 2026-05-07 | English | |
| 424B5 - InflaRx N.V. (0001708688) (Filer) | 2026-05-06 | English | |
| 6-K - InflaRx N.V. (0001708688) (Filer) | 2026-05-06 | English | |
| 6-K - InflaRx N.V. (0001708688) (Filer) | 2026-05-06 | English | |
| 6-K - InflaRx N.V. (0001708688) (Filer) | 2026-04-09 | English | |
| 6-K - InflaRx N.V. (0001708688) (Filer) | 2026-04-02 | English |
Browse filings by year
10 yearsFinancials
We couldn't load the financials
No data available yet
We have extracted financials for InflaRx N.V., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHAMPIONS ONCOLOGY, INC.
A CRO providing end-to-end solutions to accelerate oncology…
|
CSBR | US | Professional, scientific and te… |
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
A contract research organization supporting drug discovery …
|
CRL | US | Professional, scientific and te… |
|
ChemPartner PharmaTech Co., Ltd.
Global CRO and CDMO providing integrated drug discovery and…
|
300149 | CN | Professional, scientific and te… |
|
CHIMERIC THERAPEUTICS LIMITED
Clinical-stage cell therapy company developing CAR T and NK…
|
CHM | AU | Professional, scientific and te… |
|
China National Electric Apparatus Research Institute Co., Ltd.
R&D institution for electrical and electronics testing, equ…
|
688128 | CN | Professional, scientific and te… |
|
Chiome Bioscience Inc.
Clinical-stage biotech company developing antibody-based th…
|
4583 | JP | Professional, scientific and te… |
|
CHITOGENX INC
Clinical stage regenerative medicine company focused on nov…
|
CHGX | CA | Professional, scientific and te… |
|
Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment fo…
|
CMH | SE | Professional, scientific and te… |
|
Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies ta…
|
190A | JP | Professional, scientific and te… |
|
Cibus, Inc.
Develops and licenses plant traits using non-GMO precision …
|
CBUS | US | Professional, scientific and te… |
InflaRx N.V. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34234/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34234 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34234 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34234 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34234}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for InflaRx N.V. (id: 34234)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.